7-13931643-G-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PP3_ModerateBS2
The NM_004956.5(ETV1):c.661C>T(p.Pro221Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000322 in 1,461,708 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 33)
Exomes 𝑓: 0.000032 ( 0 hom. )
Consequence
ETV1
NM_004956.5 missense
NM_004956.5 missense
Scores
4
6
9
Clinical Significance
Conservation
PhyloP100: 9.35
Genes affected
ETV1 (HGNC:3490): (ETS variant transcription factor 1) This gene encodes a member of the ETS (E twenty-six) family of transcription factors. The ETS proteins regulate many target genes that modulate biological processes like cell growth, angiogenesis, migration, proliferation and differentiation. All ETS proteins contain an ETS DNA-binding domain that binds to DNA sequences containing the consensus 5'-CGGA[AT]-3'. The protein encoded by this gene contains a conserved short acidic transactivation domain (TAD) in the N-terminal region, in addition to the ETS DNA-binding domain in the C-terminal region. This gene is involved in chromosomal translocations, which result in multiple fusion proteins including EWS-ETV1 in Ewing sarcoma and at least 10 ETV1 partners (see PMID: 19657377, Table 1) in prostate cancer. In addition to chromosomal rearrangement, this gene is overexpressed in prostate cancer, melanoma and gastrointestinal stromal tumor. Multiple alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.849
BS2
High AC in GnomAdExome4 at 47 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ETV1 | NM_004956.5 | c.661C>T | p.Pro221Ser | missense_variant | 9/14 | ENST00000430479.6 | NP_004947.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ETV1 | ENST00000430479.6 | c.661C>T | p.Pro221Ser | missense_variant | 9/14 | 1 | NM_004956.5 | ENSP00000405327.1 | ||
ETV1 | ENST00000405358.8 | c.703C>T | p.Pro235Ser | missense_variant | 7/12 | 5 | ENSP00000384085.4 | |||
ETV1 | ENST00000405218.6 | c.661C>T | p.Pro221Ser | missense_variant | 8/13 | 5 | ENSP00000385551.2 | |||
ETV1 | ENST00000403685.5 | c.607C>T | p.Pro203Ser | missense_variant | 7/12 | 1 | ENSP00000385686.1 | |||
ETV1 | ENST00000403527.6 | c.541C>T | p.Pro181Ser | missense_variant | 5/10 | 1 | ENSP00000384138.1 | |||
ETV1 | ENST00000438956.6 | c.487C>T | p.Pro163Ser | missense_variant | 4/9 | 1 | ENSP00000393078.2 | |||
ETV1 | ENST00000443137.5 | n.661C>T | non_coding_transcript_exon_variant | 9/15 | 2 | ENSP00000413836.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD3 exomes AF: 0.0000201 AC: 5AN: 249286Hom.: 0 AF XY: 0.0000296 AC XY: 4AN XY: 135242
GnomAD3 exomes
AF:
AC:
5
AN:
249286
Hom.:
AF XY:
AC XY:
4
AN XY:
135242
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000322 AC: 47AN: 1461708Hom.: 0 Cov.: 32 AF XY: 0.0000358 AC XY: 26AN XY: 727136
GnomAD4 exome
AF:
AC:
47
AN:
1461708
Hom.:
Cov.:
32
AF XY:
AC XY:
26
AN XY:
727136
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
2
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 09, 2021 | The c.661C>T (p.P221S) alteration is located in exon 9 (coding exon 7) of the ETV1 gene. This alteration results from a C to T substitution at nucleotide position 661, causing the proline (P) at amino acid position 221 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;.;.;.;.;.;.;T;.;.;.
Eigen
Uncertain
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
.;D;D;D;D;D;D;D;.;D;D
M_CAP
Benign
T
MetaRNN
Pathogenic
D;D;D;D;D;D;D;D;D;D;D
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;.;.;.;M;.;.;M;.;.;.
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;D;D;D;D;D;D;D;D;D;D
REVEL
Uncertain
Sift
Benign
D;D;D;D;D;D;D;D;D;D;D
Sift4G
Benign
T;T;D;T;T;T;T;T;T;.;D
Polyphen
B;.;.;B;.;P;.;B;B;.;.
Vest4
MutPred
0.76
.;.;.;.;.;Gain of phosphorylation at P235 (P = 0.0637);.;.;.;.;.;
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at